BEY-1107P

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBEY-1107P
Drug Alias NameBEY-1107BEY-1107P
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 1 inhibitors
TargetsCyclin-dependent kinase 1
Therapy Area/IndicationsPancreatic NeoplasmsColorectal NeoplasmsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBeyondbio Inc
China Registration ClassN/A

Develop Information

Active CompaniesBeyondbio Inc
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsColorectal NeoplasmsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A